Opa VajraguptaPreecha BoonchoongYaowared SumanontHiroshi WatanabeYuvadee WongkrajangNaparat KammasudMahidol UniversityUniversity of Toyama2018-07-242018-07-242003-05-15Bioorganic and Medicinal Chemistry. Vol.11, No.10 (2003), 2329-2337096808962-s2.0-0037447937https://repository.li.mahidol.ac.th/handle/20.500.14594/20727Manganese was incorporated in the structure of the selected antioxidants to mimic the superoxide dismutase (SOD) and to increase radical scavenging ability. Five manganese complexes (1-5) showed potent SOD activity in vitro with IC50of 1.18-1.84 μM and action against lipid peroxidation in vitro with IC50of 1.97-8.00 μM greater than their ligands and trolox. The manganese complexes were initially tested in vivo at 50 mg/kg for antagonistic activity on methamphetamine (MAP)-induced hypermotility resulting from dopamine release in the mice brain. Only manganese complexes of kojic acid (1) and 7-hydroxyflavone (3) exhibited the significant suppressions on MAP-induced hypermotility and did not significantly decrease the locomotor activity in normal condition. Manganese complex 3 also showed protective effects against learning and memory impairment in transient cerebral ischemic mice. These results supported the brain delivery and the role of manganese in SOD activity as well as in the modulation of brain neurotransmitters in the aberrant condition. Manganese complex 3 from 7-hydroxyflavone was the promising candidate for radical implicated neurodegenerative diseases. © 2003 Elsevier Science Ltd. All rights reserved.Mahidol UniversityBiochemistry, Genetics and Molecular BiologyChemistryPharmacology, Toxicology and PharmaceuticsArticleSCOPUS10.1016/S0968-0896(03)00070-1